(
251
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
-
Delayed hypersensitivity to antiepileptic drugs in children
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
EAACI/ENDA position paper on drug provocation testing
-
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review – An EAACI position paper
-
Hypersensitivity reactions to biological agents: An EAACI position paper
-
Hypersensitivity reactions to chemotherapy: an EAACI position paper
-
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams – an EAACI position paper
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
Show more Position Papers (16)Show Less-
-
Advances in understanding allergen immunotherapy, drug and food allergy
-
Are children just little adults in the drug allergy diagnostic work up?
-
Betalactam hypersensitivity in children: a practical approach
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Diagnosis and Management of hypersensitivity to excipients
-
Drug allergy – time for a personalised approach
-
Exercise-induced hypersensitivity syndromes
-
Flash Talkson drug allergy
-
Flash talks on drug allergy I
-
Flash talks on drug allergy II
-
Hypersensitivity to antiepileptic drugs
-
Management of drug allergy
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Update on drug allergy
-
Update on practical approaches in delayed drug hypersensitivities
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
-
EAACI & AAAAI joint symposium: hot topics in drug hypersensitivity
-
How to classify cutaneous manifestations of drug hypersensitivity
Show more Event Resources (16)Show Less-
-
Burden of hypersensitivity reactions to biologics
-
Challenges in Drug Allergy
-
Diagnosis and management of hypersensitivity reactions due to biologics
-
Diagnosis of Drug Allergy
-
Introduction to the Drug Allergy Modules
-
Management of Common Drug Allergies
-
Pitfalls of hypersensitivity reactions due to biologics
-
Introduction to the Drug Hypersensitivity Module: Update in hypersensitive reactions to biologicals
Show more Courses (6)Show Less-
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
Immediate and delayed hypersensitivity to biologicals in children – a practical approach
-
Task force on Hypersensitivity to Excipients In Drugs
-
Update in the classification of hypersensitivity reactions to non-steroidal anti-inflammatory drugs
-
Updated guidelines on the risk assessment and methodology of skin tests for the investigation of drug allergy
-
Mechanisms and biomarkers involved in Drug Hypersensitivity Reactions
Show more Task Forces (4)Show Less-
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
EAACI/ENDA position paper on drug provocation testing
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
Show more Consensus Documents (1)Show Less-
Website
Collapse
-
“In Class Cross-Reactivity” to all tested cephalosporins revealed in a patient with Cefazolin-induced Severe Cutaneous Adverse Drug Reaction
-
A Retrospective Analysis of Drug Provocation Tests in Children with Underlying Conditions
-
A case of chronic cough induced by esophageal hypersensitivity
-
A case of progestogen hypersensitivity with reactions to endogenous progesterone and exogenous progestins
-
Advances in drug allergy diagnosis and management
-
Adverse reactions to biologicals:in vivo allergy tests as a reliable tool in hypersensitivity reactions to erenumab
-
Always in the same location. A pediatric fixed drug eruption case.
-
An eleven-year experience with drug desensitization at a fourth level center in Colombia
-
Analysis of adverse drug reactions to iodinated contrast media in a tertiary hospital: A 9-year experience
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analytical testing of PQ Grass allergoid drug product using antibodies
-
Anaphylaxis after drug provocation test with iohexol
-
Anaphylaxis and drug allergy
-
Anaphylaxis due to hypersensitivity to chlorhexidine: a case report in the perioperative environment
-
Anticonvulsant Hypersensitivity Syndrome
-
Approach to shrimp hypersensitivity in a geographic area with high prevalence of dust mites allergy: role of molecular diagnosis
-
Artificial Intelligence approaches for advancing drug development and clinical applications
-
Atypical clinical cases of fixed drug eruptions due to radiological contrast media
-
Beyond the Label: Unveiling True Beta-Lactam Hypersensitivity in a Chilean Hospital
-
Biomarker-driven drug development for allergic diseases
-
Blame the drug or the additive?
-
Can piperacillin-tazobactam be a safe alternative in patients with hypersensitivity to amoxicillin?
-
Carbamazepine induced Drug reaction with eosinophilia and systemic symptoms (DRESS) with cross-reactivity to lamotrigine confirmed by a positive rechallenge
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical history seen with different hypersensitivity reactions
-
Controversies in Drug Provocation Tests
-
Corticosteroids hypersensitivity – a decade review
-
Corticosteroids hypersensitivity – a decade review
-
Covid 19 vaccines induced acute urticaria: benign or serious hypersensitivity manifestation to vaccines?
-
Delayed Hypersensitivity Reaction to Clavulanic Acid: A Case Report
-
Delayed hypersensitivity reactions to non steroidal anti-inflammatory drugs : a cases study
-
Desensitization Protocol for Cemiplimab Immediate Hypersensitivity Reactions due to Cytokine Release in Lung Cancer: Report of 2 cases
-
Diagnosis of Hypersensitivity to Exogenous Progestogens and the Actual Utility of Allergological Tests. A Case Study
-
Differential diagnosis of Drug allergy
-
Digging Deeper the Significance of Mast Cell Tryptase Elevation in Perioperative Immediate Hypersensitivity
-
Direct drug provocation test with beta-lactams in children and adolescents
-
Drug Allergy
-
Drug Allergy: Today and Tomorrow
-
Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles
-
Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles
-
Drug allergy
-
Drug allergy
-
Drug allergy – Session 1: Diagnosis
-
Drug allergy 1
-
Drug allergy 2
-
Drug allergy 3
-
Drug allergy 4
-
Drug allergy 5
-
Drug allergy 6
-
Drug allergy 7
-
Drug allergy 8
-
Drug allergy severity and quality of life: Data from the BIOGRIAL study
-
Drug desensitization in pediatric patients – A challenging, effective and safe approach
-
Drug provocation test to acetyl salicylic acid in a children cohort
-
Drug provocation tests with beta-lactam – from suspicion to confirmation
-
Drug provocation tests: which protocol to follow?
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) caused by bortezomib and trimethoprim/sulfamethoxazole
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) concomitant to SARS cov2 infection induced by sulfasalazine with a relapse to mesalasine
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug – induced anaphylaxis in childhood
-
Drug-induced bullous drug eruptions: a case series
-
Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge
-
Endotype based classification of NSAID hypersensitivity in children
-
Evaluating NSAIDs hypersensitivity in patients chronic rhinosinusitis
-
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
-
Ferric Carboxymaltose Hypersensitivity Reactions
-
First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting
-
Fixed Drug Eruption to aminopenicillins: a case series
-
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib
-
Fixed drug eruption caused by lansoprazole
-
Fixed drug eruption caused by lansoprazole
-
Fixed drug eruption due to Levofloxacin
-
Flash talks on Drug Allergy 1
-
Flash talks on Drug Allergy 2
-
Food dependent NSAID-induced hypersensitivity – is there a link to specific components?
-
Food hypersensitivity reactions in adults: A longitudinal cohort study
-
Glutathione peroxidase single nucleotide polymorphisms associated with nonsteroidal anti-inflammatory drug hypersensitivity-induced urticaria/angioedema
-
Graded oral challenge to delabel suspected non-steroidal anti-inflammatory drugs (NSAIDs) hypersensitivity in children
-
Graded oral challenge to delabel suspected non-steroidal anti-inflammatory drugs (NSAIDs) hypersensitivity in children
-
How and when to perform skin tests for possible drug allergy
-
Hyaluronidase hypersensitivity mimicking orbital cellulitis
-
Hypersensitivity Reactions to Contrast Media: Reality from a Portuguese Tertiary Hospital
-
Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity
-
Hypersensitivity reactions in biologicals
-
Hypersensitivity reactions to Proton pump inhibitors: Patterns of cross- reactivity in a Tunisian series
-
Hypersensitivity reactions to xanthine oxidase inhibitors: Facts or myths ?
-
Hypersensitivity to Biologicals
-
Hypersensitivity to Bismuth subcitrate
-
Hypersensitivity to Corticosteroids
-
Hypersensitivity to Local anaesthetic drugs
-
Hypersensitivity to allopurinol: would desensitization be an effective procedure?
-
Hypersensitivity to antihistamines
-
Hypersensitivity to drugs used to treat allergy
-
Hypersensitivity to quinolones: the daily life in our hospital
-
Hypersensitivity to rocuronium: resolving the IgE – MRGPRX2 conundrum.
-
Hypersensitivity to sulfonamides
-
Hypersensitivity to vancomycin and quinolones
-
Identifying the most at-risk age-group and longitudinal trends of drug allergy labelling among 7.3 million individuals in Hong Kong
-
Immediate Hypersensitivity Reactions to Proton Pump Inhibitors – diagnostic workup
-
Immediate hypersensitivity reactions to corticosteroids: Clinical symptoms and cross-reactivity
-
Immediate hypersensitivity to non-steroidal anti-inflammatory drugs: a retrospective analytic descriptive study
-
Impact of the drug allergy challenges’ outcome on children and parents
-
Impact of variants in genes related to acetaminophen biodisposition on the risk of developing selective acetaminophen hypersensitivity
-
Improving NMBA hypersensitivity management using CD203c activation marker in basophil activation tests
-
Incidence of Perioperative Hypersensitivity Reactions in Spanish Hospital Cohorts – A Two-Year investigation (2022-2023)
-
Incidence of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit of Hospital Central Cruz Roja. Tree-year study
-
Innovation Hub 5 – Application of Artificial Intelligence in drug discovery: the bigger picture
-
Innovation in drug allergy education: partnerships and potential across the Asia Pacific and beyond
-
Knowledge, Attitude, and Practice of Pediatric Drug Allergy among Medical Interns: A Cross-Sectional Study
-
Long-term outcomes of drug reaction with eosinophilia and systemic symptoms: a ten-year prospective study from a tertiary center
-
Lymphocyte transformation test in the diagnosis of DRESS Syndrome: What criteria are most effective in determining drug causality?
-
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
-
Mechanisms and management of hypersensitivity induced by specific drugs
-
Multidisciplinary approach in drug allergy
-
Multiple Fixed Drug Eruption with Arylpropionics and Nolotil: A Case Report
-
Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings
-
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity Reactions: An approach to assessment, diagnosis, and management in a paediatric population
-
Non-immediate hypersensitivity reaction to different insulins: A case report
-
Novel Approaches for Drug Allergy
-
Novel analytical tool supporting drug development and biomarker discovery: The era of machine learning in Allergy and Immunology
-
OAS2 – Drug and Skin Allergy
-
Optimising Amoxicillin Hypersensitivity Assessment: A Prospective Study Investigating the Synergistic Impact of Amoxicillin and Lipopolysaccharide in Basophil Activation Testing
-
Optimising Amoxicillin Hypersensitivity Assessment: A Prospective Study Investigating the Synergistic Impact of Amoxicillin and Lipopolysaccharide in Basophil Activation Testing
-
Our experience with rapid desensitisation in delayed hypersensitivity reactions to biological drugs
-
PDS12: Drug Allergy
-
Paracetamol-induced fixed drug eruption: A case Series
-
Pediatric drug desensitizations: National experience
-
Perioperative Hypersensitivity Reactions in a Spanish Hospital Group
-
Pharmacogenetics of hypersensitivity syndrome induced by carbamazepine
-
Placebo and nocebo responses in drug allergy
-
Practical approaches to the diagnosis of hypersensitivity to Nonsteroidal Anti-inflammatory drugs
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Quinolone Hypersensitivity Investigation in a Clinical Setting
-
Rapid drug desensitization to taxanes: a descriptive study from Turkey
-
Reflection on the Role of Basophil Activation Test in the Diagnosis of Pediatric Drug Allergy
-
Related factors to cefazolin perioperative hypersensitivity reactions
-
Relevance of Administration Route in Immediate Hypersensitivity Reactions to Fluoroquinolones
-
Retrospective Analysis of Fixed Drug Eruptions: Unveiling Clinical Patterns and Identifying Causative Drugs
-
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
-
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
-
Safety of Single-Dose Drug Provocation Test in Low Risk Non-Immediate Reactions with Beta-Lactam Antibiotics in Children
-
Safety of a Three-Step Provocation Test in Mild Hypersensitivity Reactions to Beta-Lactams
-
Safety of direct and single-dose drug provocation test in low-risk penicillin allergy labels
-
Should we perform prolonged drug provocation routinely?
-
Simultaneous double drug provocation test in a low risk patient to refute unlikely allergy to paracetamol and ibuprofen
-
Successful Desensitisation for Delayed Cutaneous Kaftrio Hypersensitivity
-
Successful Desensitization with CFTR Modulatory Drugs in Delayed Cutaneous Hypersensitivity Reactions
-
Successful Rapid Desensitization in a Patient with Metastatic Colorectal Cancer Presenting with Regorafenib-Mediated Fixed Drug Eruption
-
Successful Rapid Desensitization with Atezolizumab after severe hypersensitivity reation in a patient with small-cell lung metastatic cancer: a case report
-
Successful rapid drug desensitization with adrenaline infusion pump in severe allergic reactions
-
Ten-year Survival in Children with Acute Lymphoblastic Leukemia: The Impact of L-asparaginase Hypersensitivity and Desensitization
-
The First Case Report of 12-Step 3-Bag Successful Rapid Drug Desensitization to Daratumumab in a Patient with Renal Failure Due to Secondary Systemic Amyloid and Plasma Cell Dyscrasia
-
The challenge of drug allergy: A revised nomenclature for allergic diseases is required
-
The importance of allergological workup in diagnosis of hypersensitivity to local anaesthetics
-
The use of risk assessment in drug allergy
-
Therapeutic drug monitoring of 6-thioguanine nucleotides
-
Tranexamic acid as a cause of perioperative hypersensitivity reaction
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unveiling the Impact of NSAIDs Hypersensitivity Reactions: A Tertiary Hospital Perspective
-
Visiting the emergency room with a drug allergy label. Our experience in real life
-
Vitamin D3 deficiency disturbed immune response and respiratory function in the murine model of hypersensitivity pneumonitis
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
-
A rare case of IgE-mediated multiple drug hypersensitivity syndrome
-
Adverse drug reactions to taxanes: positive skin testing correlates with breakthrough reactions during drug desensitisation
-
Clinical phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity
-
Current understanding of nonsteroidal anti-inflammatory drug hypersensitivity
-
Delayed drug hypersensitivity to bortezomib: an effective desensitization
-
Drug Hypersensitivity Reactions In A Pediatric Population Before And After COVID-19 Pandemic – A Retrospective Study In A Portuguese Hospital Center
-
Drug allergy – Session 2: Precision medicine in drug allergy
-
Drug provocation using two equal doses in patients with suspected drug allergy
-
EAACI position paper about basophil activation test in immediate drug hypersensitivity
-
Exploring Drug Hypersensitivity in Pediatric Patients with Chronic Spontaneous Urticaria: ‘’A Comprehensive Analysis Using Diagnostic Tests”
-
Frequency of Long-Term Development of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity in Patients who Underwent Nasal Polypectomy during Childhood
-
Generalised fixed drug eruption induced by propofol: A rare case of delayed type IV hypersensitivity reaction
-
Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age
-
Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age
-
Pediatric Drug Hypersensitivity
-
Riddles of drug hypersensitivity diagnosis: a case series
-
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics
-
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics
-
Variability in the genes involved in the cellular redox status, and their association with drug hypersensitivity reactions to nonsteroidal anti-inflammatory drugs and ß-lactam antibiotics
-
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
-
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
Show more Sessions (188)Show Less-